Skip to main content
Premium Trial:

Request an Annual Quote

An Arrest in the Annie Le Case

Raymond Clark III, an animal lab technician at Yale University, was arrested earlier today for the murder of Annie Le, reports the New York Times. His bail has been set at $3 million. New Haven police say he had been a "person of interest" since Monday because of bruises and scratch marks on his chest and arms and that DNA evidence later obtained also connected him to the case. Yesterday afternoon Connecticut's chief medical examiner released that the cause of Le's death was strangulation. Clark and Le worked in the same building where Le's body was found. "It is important to note that this is not about urban crime, university crime, domestic crime but an issue of workplace violence, which is becoming a growing concern around the country," says New Haven Police Chief James Lewis. Yale President Richard Levin adds in a statement that "it is frightening that a member of our own community might have committed this terrible crime. But we must not let this incident shatter our trust in one another."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.